Key result
The MATADOR-PCI registry describes combinations of antithrombotic agents used in patients with atrial fibrillation and acute coronary syndromes treated with percutaneous coronary intervention.
Why the study?
Nationwide data describing the combinations of antithrombotic therapies currently prescribed in patients with atrial fibrillation and ACS treated with PCI are scarce.
Observational
Yes
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2020) conducted an observational in Acute coronary syndromes and atrial fibrillation requiring percutaneous coronary intervention. Combinations of antithrombotic therapies was evaluated. The MATADOR-PCI registry describes combinations of antithrombotic agents used in patients with atrial fibrillation and acute coronary syndromes treated with percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: